Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Defining the Optimal Duration of Treatment for "Low-Risk" Peritoneal Dialysis-Related Peritonitis

NCT03675854 is registered in ClinicalTrials.gov with Chinese University of Hong Kong as lead sponsor.

NCT NCT03675854
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03675854 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Defining the Optimal Duration of Treatment for "Low-Risk" Peritoneal Dialysis-Related Peritonitis
Lead sponsor
Chinese University of Hong Kong
Phase
Phase 4
Overall status
Withdrawn
Start date
January 1, 2019
Completion date
September 30, 2019
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

peritoneal dialysis-associated peritonitis